Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Health news
  • Government Policies
  • From Rs 17 to Rs 2:...

From Rs 17 to Rs 2: How Team Smriti, RIL, J&J, NIV got a Covid-19 testing swab in 10 days at 10% cost of China

MD BureauWritten by MD Bureau Published On 2020-05-17T11:00:10+05:30  |  Updated On 17 May 2020 11:06 AM IST
From Rs 17 to Rs 2: How Team Smriti, RIL, J&J, NIV got a Covid-19 testing swab in 10 days at 10% cost of China
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

The ball was set rolling 10 days back for the indigenous project for nasal and throat swabs when Ravi Kapoor, Secretary, Textiles contacted J&J and RIL to check whether India can manufacture swab required for testing purpose.

New Delhi: India has achieved a major milestone in its fight against Covid-19 as two large companies Reliance Industries Limited (RIL) and Johnson & Johnson collaborated as part of a social contract with National Institute of Virology and Textiles Ministry to get a Made in India testing swab in 10 days at 10 per cent cost of what was being imported from China.

This is the story of how the government and private sector have worked on a war footing for a breakthrough in a crucial testing input of nasal and throat swabs at affordable pricing which were being imported from China until just 10 days back.

This is seen as a major achievement for the Vocal for Local campaign announced by Prime Minister Narendra Modi.

Textiles Minister Smriti Irani said in a tweet, "Government efforts & our industry's prowess have proved that our Nation has capacity & ability to tide over every obstacle. India's success in the production of PPE & Testing Swabs has already put our Nation on the path of 'Atmanirbhar Bharat' as enunciated by PM @narendramodiJi".

Varun Jhaveri, Officer on Special Duty, Ayushman Bharat said in a tweet, "We used to import collection swabs at Rs 17 from China. Govt contacted the largest Indian polyester manufacturer to locally design swab. Got the design & material approved from NIV & gave manufacturing orders to MSMEs. Today, India manufactures these at Rs 2! Vocal for Local!".

The ball was set rolling 10 days back for the indigenous project for nasal and throat swabs when Ravi Kapoor, Secretary, Textiles contacted J&J and RIL to check whether India can manufacture swab required for testing purpose.

The video conference was held between Ravi Kapoor and his team, J&J and their team and RIL officials. A question was raised whether in shortest time period whether such swab can be manufactured in India in required quantity.

Since ear buds are manufactured by J&J, the issue raised was whether such swab can be manufactured, which are suitable for carrying out corona testing.

It was also stated that Chinese swabs were costing Rs 17 and difficult to get hence this swabs can be manufactured with the help of J&J and RIL?

It was also stated whether the cotton used on surface can be replaced with polyester so that the tissues taken out on swab can be sent to testing labs.

RIL agreed to this requirement swiftly and sent polyester staple fibre to National Institute of Virology in Pune for testing. This was tested by NIV and the material was approved.

However, more demanding requirements were on the anvil in this short journey. The J&J unit at Vasai which was manufacturing ear buds needed sliver made out of PSF to feed to their automatic machines to manufacture these swabs. These slivers were made from PSF of 38mm usual cut length.

This was done in the RIL RTG Patalganga having prototype machine to produce sliver. This sliver was sent to MSME at Vasai to try out on their automatic machines. Since machines to produce ear bud could accommodate cut length up to 25mm (cotton) this sliver supplied of 38mm fiber could not meet their requirement.

Thereafter, RIL was asked to supply sliver to meet machine requirement. "Our scientist worked overnight on right type of PSF of cut length 22mm with change of certain characteristic to produce sliver to meet requirement of automatic machines. This was done within 12 hours from the intimation received," officials from RIL said.

These slivser were approved and were suitable for this machine and sample was prepared to be sent to NIV for their final approval by J&J team and this was approved by NIV within 12 hours of time.

It was also a challenge to move the cartons to Vasai plant in view of lockdown conditions. Special passes and other arrangements were made to move the material from PG to Vasai.

The target of the exercise was to manufacture this swab at the lowest cost. The present cost of making swab based on material supplied by RIL is in the range of Rs 1.70 to 1.75/swab, as against imported cost of Rs 17/pc. Officials said this cost can be further brought down once the Vasai unit get their new machine to accommodate longer stick rather than using adaptor which required manual intervention.

Officials said this does not make commercial sense to make the swab but it is doing it in national interest.

"This swab requires .03 grams of PSF/swab hence commercially does not make sense for RIL to get involved for such a small quantity. However, our commitment to India for providing swab was the ultimate goal because without swab no test could be carried out," RIL officials said.

"We in RIL spent day and night to provide sliver required for manufacturing swabs at Vasai with the help of J&J in shortest time period of 8 days, which normally would have taken a few months to complete the project. We at Reliance take pride to work for Nation's need rather than looking into commercial aspects," they added.

"This is one of the targets for Make in India project rather than made for India project. This also eliminates some of the over dependence on China for such critical item required for national interest. Our target will be to manufacture super speciality fibres required for defence and other critical end uses which are being imported and India is vulnerable for such imports and dictation from the supplier," they added.

smriti iraniReliance Industriesjohnson and johnsoncoronavirusvocalforlocalcoronavirus testing
Source : IANS
MD Bureau
MD Bureau

    Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Can Just a Few Nights of Poor Sleep Increase Your Risk of Heart Disease? Study Finds Out

    Can Just a Few Nights of Poor Sleep Increase Your Risk of Heart Disease? Study Finds Out

    View All

    Health News Today

    Health Bulletin 12/ May/ 2025

    Health Bulletin 12/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok